Thursday, May 1, 2014
Publication and contact
IL-1 receptor-like 1 (IL1RL1;
Mouse and cell culture
studies suggest inhibiting IL-33 signaling could help treat Gleevec
CML. CD34+ cells from patients with CML had surface expression
of ST2 and greater proliferation in response to IL-33 than CD34+ cells from healthy subjects. IL-33 is an activating
ligand for ST2. In patient-isolated CD34+ cells,
IL-33 blocked the effect of Gleevec on proliferation. Next steps could
include evaluating IL-33 inhibitors in combination with Gleevec in models of
AG markets Gleevec, a BCR-ABL
tyrosine kinase inhibitor, to treat CML, acute
lymphoblastic leukemia (ALL) and gastrointestinal stromal tumors (GISTs).
an anti-IL-33 antibody, is in discovery for various inflammatory conditions.
Published online May 1, 2014
Patent and licensing status
Levescot, A. et al.
Cancer Res.; published online March 27, 2014;
Contact: Andre Herbelin, Institut National de la Santé et de
la Recherche Médicale (INSERM), Poitiers, France
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]